| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $900.8M | +16.9% |
| R&D Expense | $72.4M | -1.3% |
| SG&A Expense | $232.4M | +6.8% |
| Operating Income | $186.5M | +51.4% |
| Pre-tax Income | $206.1M | +209.3% |
| Income Tax | $37.9M | +123.9% |
| Net Income | $109.2M | -35.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $85.7M | +28.2% |
| Accounts Receivable | $1.9M | +276.7% |
| Current Assets | $764.6M | +15.5% |
| Total Assets | $1.30B | +9.1% |
| Current Liabilities | $759.9M | +18.2% |
| Total Liabilities | $1.10B | +14.8% |
| Stockholders' Equity | $177.7M | -10.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $372.5M | +26.0% |
| Capital Expenditures | $29.3M | +144.3% |
| Investing Cash Flow | -$97.1M | -185.3% |
| Financing Cash Flow | -$257.3M | +35.9% |
| Free Cash Flow | $343.1M | +21.0% |